Prialt (ziconotide) / Jazz - LARVOL DELTA

Practical guide to intrathecal drug delivery: short-term and long-term management and complications. (PubMed, Reg Anesth Pain Med) - "Intrathecal pharmacologic strategies for pain are examined, including opioids, local anesthetics, ziconotide, clonidine, and baclofen, with attention to indication-specific dosing, titration, and safety considerations.Clinical outcomes are framed beyond pain intensity alone, emphasizing functional improvement, quality of life, and reduction in systemic medication use as clinically meaningful endpoints. International and regional practice variations are also discussed to contextualize differences in drug availability, compounding practices, and reimbursement. By consolidating pragmatic guidance across the full lifecycle of intrathecal therapy, this guide aims to support consistent, safe, and effective use of IDD for complex pain management in contemporary practice."

Journal • Review • Anesthesia • Oncology • Pain

Resolving conformational polymorphism in disulfide-rich peptide drugs. (PubMed, Front Chem) - "Here, cyclic ion mobility-mass spectrometry (cIM-MS), combined with accelerated thermal stress testing, was applied to a manufacturing batch of ziconotide and linaclotide under native and thermally stressed conditions. The high-resolution separation achieved by cIM-MS enabled detailed mapping of coexisting conformers and their stress-induced transitions. These results demonstrate that cIM-MS provides a spatially resolved analytical platform for interrogating higher-order structural heterogeneity in disulfide-rich peptide therapeutics, extending the capabilities of conventional mass spectrometry and offering a generalizable approach for structural characterization and quality assessment."

Journal

From bench to bedside: experimental pharmacology approaches to overcome bioavailability, stability, and translational barriers of bioactive peptides from natural sources. (PubMed, Front Pharmacol) - "Success stories (ziconotide, lactotripeptides IPP/VPP) versus stalled candidates highlight the decisive role of integrated experimental pharmacology data...Rigorous experimental pharmacology, rather than bioactivity alone, is the key to bridging the bench-to-bedside gap for natural bioactive peptides. A standardized translational workflow from discovery to IND filing is proposed to accelerate clinical application of these promising molecules."

Journal • Review • Oncology

Acute Sensorimotor Collapse After Ultralow Dose Intrathecal Ziconotide-Mimicking Spinal Cord Catastrophe. (ASA 2026) - "Recognition of this rare toxicity is critical to guide escalation of care. QI efforts should focus on protocolizing dosing, preparing patients for potential side effects and extending neurological monitoring to enhance safety and clinical decision making."

Ataxia • CNS Disorders • Movement Disorders • Neuralgia • Orthopedics

Intrathecal Ziconotide Long-Term Management in Chronic Postamputation Pain. (PubMed, Case Rep Anesthesiol) - "After 15 years of treatment with ziconotide infusion, the patient achieved sustained analgesic control and excellent functional recovery. IT ziconotide showed good long-term tolerability and safety."

Journal • Musculoskeletal Pain • Pain

Targeting Cav2.2 channels for pain management: challenges, innovations, and future perspectives. (PubMed, Biochem Pharmacol) - "Although ziconotide is clinically effective, its use is hampered by a narrow therapeutic window and severe side effects...We focus on emerging therapeutic strategies developed in recent years, including the optimization of direct blockade, the inhibition of channel trafficking, the modulation of signaling pathways, and targeted channel depletion. These advancements provide a deeper understanding of calcium channel regulation and identify promising targets for safer, more effective, and precision-based pain management."

Journal • Review • Pain • CACNA1B • CAV2

A magnetic polymer adsorbent based on porous polystyrene microspheres for efficient extraction of conotoxins in biological fluids. (PubMed, Analyst) - "In this work, we employed α-conotoxin ImI (α-ImI) and ziconotide as model peptides...The established method was characterized by good linearity (R2 above 0.9993), acceptable sensitivity (LODs below 0.03 μg mL-1), high accuracy (recoveries ranging from 85.3% to 92.9%) and excellent repeatability (RSDs varied from 1.3% to 2.8%). Furthermore, the adsorbent maintained good reusability over six adsorption-desorption cycles, indicating its potential as an efficient candidate for pharmacokinetic studies of conotoxins."

Journal

A targeted partial reduction Cyanylation strategy coupled with HRMS for accurate disulfide bridge mapping in Disulfide rich cyclic peptides. (PubMed, J Chromatogr A) - "Notably, it enables reliable differentiation of disulfide isomers that are otherwise indistinguishable using routine analytical techniques. Overall, this study establishes a practical and robust method for disulfide bond mapping in cyclic peptides, with broad applicability for structural characterization and quality assessment and don't require enzymatic digestion or specialized instrumentation.The methodology was successfully validated using Linaclotide, Plecanatide, and Ziconotide, which contain three, two, and three disulfide bridges, respectively."

Journal

Clinical Advances in Analgesic Drug Development from Ion Channel Modulators. (PubMed, Curr Med Chem) - "It systematically discusses each aforementioned channel class, including VGCCs, VGSCs, VGKCs, TRPs, nAChRs, P2X, and ASICs, highlighting breakthrough drugs (e.g., ziconotide for VGCCs) and summarizing recent advances in clinical trials for emerging candidates. By elucidating both the successes and challenges in translating ion channel-targeted therapies, this review underscores their potential to overcome the limitations of conventional analgesics. This study aims to inform future research directions and accelerate the development of optimized, mechanism-based pain therapeutics."

Journal • Addiction (Opioid and Alcohol) • CNS Disorders • Pain • Psychiatry

Antioxidant, Anti-Inflammatory and Anticancer Peptides from Extreme Marine Environments. (PubMed, Antioxidants (Basel)) - "Ziconotide (Prialt), a neurotoxic peptide derived from the venom of a marine snail (Conus sp.) found at depths greater than 1000 m, is already commercially available for the treatment of severe pain...Overall, the review reports about eight peptides with anticancer properties from deep environments, nine, two and seven from polar habitats with antioxidants, anti-inflammatory and anticancer properties, respectively, and approximately ninety peptides from tropical waters (five antioxidant, thirty-five anti-inflammatory and fifty-four anticancer peptides). However, future studies in extreme environments will need to develop and apply sampling technologies, cultivation systems, as well as methods to assess efficacy, side effects and mechanisms of action, in vitro and in vivo."

Journal • Review • Oncology • Pain

Real-Life Data on Ziconotide-Based Intrathecal Therapy in Patients With Cancer Pain: Interim Analysis of the Observational Practice in Clinics Registry. (PubMed, Neuromodulation) - P | "IT therapy combining ziconotide with morphine and a local anesthetic is an effective option for managing cancer-related pain in patients who have inadequate response to, or poor tolerance of, conventional systemic analgesics."

Journal • Anesthesia • Cognitive Disorders • Constipation • Gastroenterology • Gastrointestinal Disorder • Oncology • Pain

Marine metabolites as biomedical resources: Innovative sea-based strategies for human health. (PubMed, Biomed Mater) - "Representative case studies, including ziconotide for pain management and trabectedin for cancer treatment, highlight the successful translation of marine metabolites from discovery to clinical use. Looking ahead, the impact of climate change on marine biodiversity poses additional challenges to the availability and compositional consistency of marine resources, necessitating adaptive and sustainable sourcing strategies. Overall, this review underscores the critical importance of continued and responsible exploration of marine biodiversity to support innovative and effective therapeutic solutions for human health."

Journal • Cardiovascular • CNS Disorders • Metabolic Disorders • Oncology • Pain

Functional crosstalk between neuropeptide FF system and N-type voltage-gated calcium channels in ziconotide-mediated antinociception in mice. (PubMed, Psychopharmacology (Berl)) - No abstract available

Journal • Preclinical

From marine predator to pharmacology: Conotoxin diversity, discovery, and therapeutic potential. (PubMed, Zool Res) - "Their significant therapeutic potential is underscored by efficacy in chronic pain management, exemplified by the US FDA-approved drug ziconotide, and by growing evidence supporting applications in neuroprotection in disorders such as Alzheimer's disease and Parkinson's disease, as well as in selected cardiovascular conditions. Future perspectives are also discussed, with progress likely dependent on the integration of computational design, peptide engineering, and bioengineering platforms to accelerate the translation of these marine peptides into next-generation clinical therapeutics."

Journal • Review • Alzheimer's Disease • Cardiovascular • CNS Disorders • Movement Disorders • Pain • Parkinson's Disease

Selecting Neuromodulation Devices For Chronic Pain Conditions: A Narrative Review. (PubMed, Pain Physician) - "Neuromodulation continues to advance at the intersection of neuroscience, bioengineering, and clinical practice. Harmonizing definitions, classifications, and education will guide future innovation and help ensure that neuromodulation fulfills its promise of safe, effective, and equitable patient care."

Journal • Review • CNS Disorders • Diabetic Neuropathy • Migraine • Musculoskeletal Pain • Neuralgia • Pain

Recent Applications of Disulfide Bond-Containing Compounds in Medicinal and Agrochemical Chemistry. (PubMed, J Agric Food Chem) - "In the medical field, disulfide bonds are crucial for stabilizing bioactive molecules like insulin and ziconotide, enhancing their efficacy...However, challenges like low large-scale synthesis efficiency, poor agrochemical field stability, resistance risks, and unclear environmental fate remain. The study concludes that optimizing synthesis, developing stable formulations, and exploring controllable disulfide bond technologies will further unlock the potential of these compounds, driving progress in human health and sustainable agriculture."

Journal • Review

Efficacy and safety of the Cav2.2 blocker Ziconotide in pain: a meta-analysis and systematic review. (PubMed, Pain Rep) - "Although Ziconotide shows promise as an intrathecal treatment for refractory pain, its frequent adverse effects, the availability of high-certainty evidence, and inconclusive impact on opioid consumption highlight the need for cautious use. This meta-analysis underscores the need for future research."

Journal • Retrospective data • Review • Pain • CACNA1B • CAV2

Ziconotide as an Opioid Rescue: Economic, Clinical, and Subgroup Considerations [Letter]. (PubMed, J Pain Res) - No abstract available

Journal

A Case of Abrupt Cessation of Intrathecal Clonidine (ASRA-FALL 2025) - "Case Presentation: A 70-year-old man with refractory neuropathic pain secondary to bilateral lower-extremity complex regional pain syndrome was managed with an intrathecal drug delivery system infusing fentanyl (350 mcg/day), ziconotide (6.56 mcg/day), and clonidine (450 mcg/day)...The 3 FDA approved intrathecal medications include morphine, baclofen, and ziconotide...Once stabilized after 72 hours, he was transitioned to the medical floor with as-needed oral hydralazine and continuation of oral and transdermal clonidine...In this case, the patient’s opioid withdrawal was effectively managed with oral methadone 5 mg TID...Outcome: The patient's infection resolved with targeted antibiotics. Clonidine withdrawal was successfully managed with combination of oral and transdermal clonidine followed by taper schedule on hospital discharge (tapered off oral clonidine first then transdermal clonidine)."

Clinical • Late-breaking abstract • Addiction (Opioid and Alcohol) • Cardiovascular • CNS Disorders • Dermatology • Gastrointestinal Disorder • Hypertension • Infectious Disease • Musculoskeletal Pain • Neuralgia • Psychiatry

Directing the oxidative folding of disulfide-rich peptides for enhanced engineering and applications. (PubMed, Chem Sci) - "These attributes drive their utility as high-affinity molecular tools in bioanalytics/chemical biology and clinically validated therapeutics (e.g., ziconotide for chronic pain and insulin for diabetes)...Herein, we summarize novel strategies that actively direct the oxidative folding of DRPs to enhance their engineering and applications. Additionally, we present our perspective on key challenges in DRP design and discovery associated with oxidative folding, and propose future research directions to advance this field."

Journal • Review • Diabetes • Metabolic Disorders • Pain

Can Ziconotide Be Used to Replace Opioids? Exploratory Clinical Experience in 5 Patients Treated in the Pain Unit. (PubMed, J Pain Res) - "Intrathecal opioid rescue with ziconotide emerges as a viable therapeutic option for patients with refractory pain and a neuropathic component, or for those who develop adverse events associated with IT morphine. Low doses and slow titration of ziconotide may help minimize adverse events while maintaining analgesic benefit."

Journal • Colon Cancer • Colorectal Cancer • Constipation • Endocrine Disorders • Gastroenterology • Gastrointestinal Disorder • Genetic Disorders • Musculoskeletal Pain • Oncology • Osteosarcoma • Pain • Sarcoma • Solid Tumor

The role and behavior of voltage-gated calcium channels annels in ischemia/reperfusion. (PubMed, Cell Signal) - "Experimental studies demonstrating the protective effects of VGCC inhibitors-such as nimodipine, mibefradil, and SNX-111-are critically evaluated along with their translational limitations. By integrating up-to-date mechanistic insights with preclinical and early clinical data, this review highlights VGCCs as promising molecular targets for preventing I/R injury. Future therapeutic strategies should focus on isoform-specific targeting, time-dependent administration, and organ-directed formulations to enhance efficacy and safety."

Journal • Review • Cardiovascular • Metabolic Disorders • Reperfusion Injury

Animal Venom in Modern Medicine: A Review of Therapeutic Applications. (PubMed, Toxins (Basel)) - "Successful venom-derived drugs like captopril and ziconotide exemplify the translational potential of this biological arsenal. By synthesizing current findings and future directions, this review underscores the transformative potential of animal venoms in modern pharmacotherapy and drug development. We also discuss current therapeutic limitations and how venom-derived compounds may address unmet needs in specific disorders."

Journal • Review • Cardiovascular • Hematological Disorders • Infectious Disease • Oncology • Pain • Thrombosis

Spinal analgesia in cancer pain management-MASCC general practice recommendations. (PubMed, Support Care Cancer) - "Morphine and hydromorphone are the opioids of choice for IT treatment...Ziconotide requires a slow dose titration, but it can be used in small volumes...The use of boluses of hydrophilic opioids, like morphine, for treating breakthrough pain may be inadequate, as intrathecal opioids alone may be unable to adequately treat an episode of rapid pain onset and duration. The decision-making process for employing interventional therapies, like spinal analgesia, should be shared, taking into account the actual indications and needs, previous treatments, prognosis, timing, advantages and disadvantages, and complications, in any individual situation, managing all the aspects of care."

Journal • Review • Anesthesia • Oncology • Pain • Palliative care

Recurrent Ziconotide-Associated Delirium and Psychosis: A Case Report. (PubMed, J Clin Psychopharmacol) - No abstract available

Journal • CNS Disorders • Psychiatry